Molecular diagnostics which is based on PCR methods (e.g. Real Time - PCR) is a sensitive test, whose primary limitation is difficulty in appropriate material selection. According to the recommendations the biopsy of skin lesions is the best material to make this test but analysis of systemic fluids such as: urine, blood or cerebrospinal fluid is also accepted. It should be remembered, however, that probability of bacteria detecting in systemic fluids is lower due to less frequent presence of this pathogen in the analyzed sample.
CB DNA test services include of all RUO (Research Use Only) tests which are designed only for the research purposes. Result of this tests is only for informational purposes and does not have a diagnostic test status.
The test consists in detecting the presence and/ or marking the number of DNA copies of bacteria Mycoplasma pneumoniae causing mycoplasmosis.
Symptoms of the disease are differentiated, from a minor infection of upper respiratory tracts to acute pneumonia, besides it can be accompanied by complications in respect of the nervous system, heart, joints or pancreas, quite frequent are skin symptoms in form of rash, erythema, ulcerative stomatitis or conjunctivitis.
The progress of mycoplasma infection may be asymptomatic in case of 10%-20% of people. In 60%-80% of cases it develops as upper respiratory tract infection or inflammation of the trachea and bronchi. In some cases, recurring pneumonia may develop or complications in respect of the nervous system, heart, joints or pancreas. Typical infection symptoms include: small fever, catarrh, headaches and sore throat, chronic dry cough. Infection with M. pneumonia mainly develops with droplet forms.
Test material: whole blood (EDTA) swab of nasopharyngeal cavity, sputum, bronchi washings
Transfer method: temp. 4-8°C
Testing method: Real-Time PCR
Delivery date: up to 7 working days (for an extra fee /200zl/ the delivery date is up to 48 hours after delivery sample to the laboratory)